Notice2024-10134
Request for Information on the Development of the Fiscal Years 2026-2030 NIH-Wide Strategic Plan for Sexual & Gender Minority Health Research
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
May 9, 2024
Issuing agencies
Health and Human Services DepartmentNational Institutes of Health
Abstract
Through this Request for Information (RFI), the Sexual & Gender Minority Research Office (SGMRO) in the Division of Program Coordination, Planning, and Strategic Initiatives (DPCPSI), Office of the Director (OD), National Institutes of Health (NIH), invites feedback from the scientific research community, clinical practice communities, patient and family advocates, scientific or professional organizations, federal partners, internal NIH stakeholders, and other interested constituents on the development of the Fiscal Years 2026- 2030 NIH-Wide Strategic Plan for Sexual and Gender Minority Health Research. This plan will describe future directions in sexual and gender minority (SGM) health and research to optimize NIH's research investments.
Full Text
<html>
<head>
<title>Federal Register, Volume 89 Issue 91 (Thursday, May 9, 2024)</title>
</head>
<body><pre>
[Federal Register Volume 89, Number 91 (Thursday, May 9, 2024)]
[Notices]
[Pages 39631-39632]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2024-10134]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Request for Information on the Development of the Fiscal Years
2026-2030 NIH-Wide Strategic Plan for Sexual & Gender Minority Health
Research
AGENCY: National Institutes of Health, HHS.
ACTION: Request for information.
-----------------------------------------------------------------------
SUMMARY: Through this Request for Information (RFI), the Sexual &
Gender Minority Research Office (SGMRO) in the Division of Program
Coordination, Planning, and Strategic Initiatives (DPCPSI), Office of
the Director (OD), National Institutes of Health (NIH), invites
feedback from the scientific research community, clinical practice
[[Page 39632]]
communities, patient and family advocates, scientific or professional
organizations, federal partners, internal NIH stakeholders, and other
interested constituents on the development of the Fiscal Years 2026-
2030 NIH-Wide Strategic Plan for Sexual and Gender Minority Health
Research. This plan will describe future directions in sexual and
gender minority (SGM) health and research to optimize NIH's research
investments.
DATES: The SGMRO's RFI is open for public comment for a period of 60
days. Comments must be received on or before 11:59:59 p.m. ET, June 26,
2024, to ensure consideration. After the public comment period has
closed, comments received by SGMRO will be considered in a timely
manner for the development of the Fiscal Years 2026-2030 NIH-Wide
Strategic Plan for SGM Health Research.
How To Submit a Response
All responses should be submitted electronically at the RFI
submission website, <a href="https://rfi.grants.nih.gov/?s=660c63fa171bc46e9c038e92">https://rfi.grants.nih.gov/?s=660c63fa171bc46e9c038e92</a>, by 11:59:59 p.m. (ET) on June 26, 2024.
You will receive an electronic confirmation acknowledging receipt of
your response.
FOR FURTHER INFORMATION CONTACT: Irene Avila, Ph.D., Assistant
Director, Sexual & Gender Minority Research Office (SGMRO),
<a href="/cdn-cgi/l/email-protection#287b6f657a6768464140064f475e"><span class="__cf_email__" data-cfemail="34677379667b745a5d5c1a535b42">[email protected]</span></a>, (301) 594-9701.
SUPPLEMENTARY INFORMATION:
Background: ``Sexual and gender minority'' is an umbrella term that
includes, but is not limited to, individuals who identify as lesbian,
gay, bisexual, asexual, transgender, Two-Spirit, queer, and/or
intersex. Individuals with same-sex or -gender attractions or behaviors
and those with variations in sex characteristics are also included.
These populations also encompass those who do not self-identify with
one of these terms but whose sexual orientation, gender identity or
expression, or reproductive development is characterized by non-binary
constructs of sexual orientation, gender, and/or sex.
The Sexual and Gender Minority Research Office (SGMRO) at <a href="https://dpcpsi.nih.gov/sgmro">https://dpcpsi.nih.gov/sgmro</a> coordinates sexual and gender minority (SGM)-
related research and activities by working directly with the National
Institutes of Health (NIH) Institutes, Centers, and Offices. The Office
was officially established in September 2015 within the NIH Division of
Program Coordination, Planning, and Strategic Initiatives in the Office
of the Director.
This Federal Register notice is in accordance with the 21st Century
Cures Act, requiring NIH to regularly update their strategic plans. In
2020, NIH launched its Strategic Plan to Advance Research on the Health
and Well-being of Sexual and Gender Minorities, Fiscal Years (FY) 2021-
2025 at <a href="https://dpcpsi.nih.gov/sites/default/files/SGMStrategicPlan_2021_2025.pdf">https://dpcpsi.nih.gov/sites/default/files/SGMStrategicPlan_2021_2025.pdf</a>. The current strategic plan is NIH's
second strategic plan focused on SGM health research and has provided
the NIH with a framework to improve the health of SGM populations
through increased research and support of scientists conducting SGM
health-related research. In January 2023, SGMRO published a mid-course
review at <a href="https://dpcpsi.nih.gov/sites/default/files/2023-09/SGMRO-StrategicPlan-MidCourseReview-Report-5-508.pdf">https://dpcpsi.nih.gov/sites/default/files/2023-09/SGMRO-StrategicPlan-MidCourseReview-Report-5-508.pdf</a> of the current NIH SGM
strategic plan that provided recommendations to support further
progress on the goals described therein. To establish NIH priorities in
SGM health-related research for the next five years, SGMRO requests
input from SGM health, research, and related communities in refining
the goals of the FY26-FY30 strategic plan.
Request for Comment on the NIH-Wide SGM Health Research Strategic
Plan FY26--FY30: NIH is developing a strategic plan to advance SGM
research in FY26-FY30. This RFI invites input from interested parties
throughout the scientific research, advocacy, and clinical practice
communities, federal partners, those employed by the Department of
Health and Human Services (HHS) and NIH or at institutions receiving
NIH support as well as the general public, regarding the below topics
for the NIH-Wide Strategic Plan for SGM Health Research. This input is
a valuable component in developing the SGM health research strategic
plan, and the community's time and consideration are appreciated. NIH
seeks comments and/or suggestions from all interested parties on the
following topics:
<bullet> The highest priority needs, and emerging areas of
opportunity related to SGM health research at NIH.
<bullet> Actions that NIH should prioritize to advance SGM health-
related research.
<bullet> Partnerships NIH should pursue, both inside and outside of
government, to advance SGM health-related research.
<bullet> Any other relevant topics that NIH should consider when
developing the next NIH-Wide strategic plan for SGM health research.
NIH encourages organizations (e.g., patient advocacy groups,
professional organizations) to submit a single response reflective of
the views of the organization or membership as a whole. Responses to
this RFI are voluntary. Do not include any proprietary, classified,
confidential, trade secret, or sensitive information in your response.
The responses will be reviewed by NIH staff, and individual feedback
will not be provided to any responder. The Government will use the
information submitted in response to this RFI at its discretion. The
Government reserves the right to use any submitted information on
public NIH websites; in reports; in summaries of the state of the
science; in any possible resultant solicitation(s), grant(s), or
cooperative agreement(s); or in the development of future funding
opportunity announcements.
This RFI is for information and planning purposes only and should
not be construed as a solicitation for applications or proposals, or as
an obligation in any way on the part of the United States Federal
Government, NIH, or individual NIH Institutes, Centers, and Offices to
provide support for any ideas identified in response to it. The Federal
Government will not pay for the preparation of any information
submitted or for the Government's use of such information.
No basis for claims against the U.S. Government shall arise as a
result of a response to this RFI or from the Government's use of such
information. Additionally, the Government cannot guarantee the
confidentiality of the information provided.
Dated: May 2, 2024.
Lawrence A. Tabak,
Principal Deputy Director, National Institutes of Health.
[FR Doc. 2024-10134 Filed 5-8-24; 8:45 am]
BILLING CODE 4140-01-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on May 9, 2024.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.